Clinical Trials

NCT02971748 | ACTIVE_NOT_RECRUITING | PHASE2
36 participants

Pembrolizumab in Treating Patients With Hormone Receptor Positive, Localized Inflammatory Breast Cancer Who Are Receiving Hormone Therapy and Did Not Achieve a Pathological Complete Response to Chemotherapy

Study Type:
INTERVENTIONAL
Last Updated:
2026-06-11
Start Date:
2017-01-26
Completion:
2025-12-10
Conditions
  • Anatomic Stage IIIB Breast Cancer AJCC v8
  • Anatomic Stage IIIC Breast Cancer AJCC v8
  • Breast Inflammatory Carcinoma
  • Prognostic Stage IIIB Breast Cancer AJCC v8
  • Prognostic Stage IIIC Breast Cancer AJCC v8
Interventions
  • BIOLOGICAL
NCT02910700 | ACTIVE_NOT_RECRUITING | PHASE2
52 participants

Nivolumab With Trametinib and Dabrafenib, or Encorafenib and Binimetinib in Treating Patients With BRAF Mutated Metastatic or Unresectable Stage III-IV Melanoma

Study Type:
INTERVENTIONAL
Last Updated:
2026-06-11
Start Date:
2016-12-09
Completion:
2027-12-08
Conditions
  • Metastatic Malignant Neoplasm in the Brain
  • Metastatic Melanoma
  • Stage III Cutaneous Melanoma AJCC v7
  • Stage IIIA Cutaneous Melanoma AJCC v7
  • Stage IIIB Cutaneous Melanoma AJCC v7
  • Stage IIIC Cutaneous Melanoma AJCC v7
  • Stage IV Cutaneous Melanoma AJCC v6 and v7
  • Unresectable Melanoma
Interventions
  • DRUG
  • OTHER
  • BIOLOGICAL
No Results Yet
NCT02726997 | ACTIVE_NOT_RECRUITING | PHASE1/PHASE2
18 participants

Matched Paired Pharmacodynamics and Feasibility Study of Durvalumab in Combination With Chemotherapy in Frontline Ovarian Cancer (N-Dur)

Study Type:
INTERVENTIONAL
Last Updated:
2026-06-11
Start Date:
2016-07-06
Completion:
2027-12-31
Conditions
  • Stage III Fallopian Tube Cancer AJCC v7
  • Stage III Ovarian Cancer AJCC v6 and v7
  • Stage III Primary Peritoneal Cancer AJCC v7
  • Stage IIIA Fallopian Tube Cancer AJCC v7
  • Stage IIIA Ovarian Cancer AJCC v6 and v7
  • Stage IIIA Primary Peritoneal Cancer AJCC v7
  • Stage IIIB Fallopian Tube Cancer AJCC v7
  • Stage IIIB Ovarian Cancer AJCC v6 and v7
  • Stage IIIB Primary Peritoneal Cancer AJCC v7
  • Stage IIIC Fallopian Tube Cancer AJCC v7
  • Stage IIIC Ovarian Cancer AJCC v6 and v7
  • Stage IIIC Primary Peritoneal Cancer AJCC v7
  • Stage IV Fallopian Tube Cancer AJCC v6 and v7
  • Stage IV Ovarian Cancer AJCC v6 and v7
  • Stage IV Primary Peritoneal Cancer AJCC v7
Interventions
  • DRUG
  • BIOLOGICAL
  • OTHER
No Results Yet
NCT02503722 | ACTIVE_NOT_RECRUITING | PHASE1
36 participants

Testing the Combination of MLN0128 (TAK-228) and AZD9291 in Advanced EGFR (Epidermal Growth Factor Receptor) Mutation Positive Non-small Cell Lung Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-06-11
Start Date:
2017-03-23
Completion:
2027-02-28
Conditions
  • Metastatic Lung Non-Small Cell Carcinoma
  • Recurrent Lung Non-Small Cell Carcinoma
  • Stage III Lung Non-Small Cell Cancer AJCC v7
  • Stage IIIA Lung Non-Small Cell Cancer AJCC v7
  • Stage IIIB Lung Non-Small Cell Cancer AJCC v7
  • Stage IV Lung Non-Small Cell Cancer AJCC v7
Interventions
  • OTHER
  • DRUG
No Results Yet
NCT02079662 | ACTIVE_NOT_RECRUITING | NA
110 participants

The Role of Lifestyle Factors in Breast Cancer-Related Outcomes

Study Type:
INTERVENTIONAL
Last Updated:
2026-06-11
Start Date:
2013-06-13
Completion:
2030-12-31
Conditions
  • Stage II Breast Cancer AJCC v6 and v7
  • Stage IIA Breast Cancer AJCC v6 and v7
  • Stage IIB Breast Cancer AJCC v6 and v7
  • Stage III Breast Cancer AJCC v7
  • Stage IIIA Breast Cancer AJCC v7
  • Stage IIIB Breast Cancer AJCC v7
  • Stage IIIC Breast Cancer AJCC v7
Interventions
  • OTHER
  • BEHAVIORAL
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page